BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 27609256)

  • 21. Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry.
    Guerrero M; Dvir D; Himbert D; Urena M; Eleid M; Wang DD; Greenbaum A; Mahadevan VS; Holzhey D; O'Hair D; Dumonteil N; Rodés-Cabau J; Piazza N; Palma JH; DeLago A; Ferrari E; Witkowski A; Wendler O; Kornowski R; Martinez-Clark P; Ciaburri D; Shemin R; Alnasser S; McAllister D; Bena M; Kerendi F; Pavlides G; Sobrinho JJ; Attizzani GF; George I; Nickenig G; Fassa AA; Cribier A; Bapat V; Feldman T; Rihal C; Vahanian A; Webb J; O'Neill W
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1361-71. PubMed ID: 27388824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
    Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - a contemporary experience.
    Cohen MG; Singh V; Martinez CA; O'Neill BP; Alfonso CE; Martinezclark PO; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):987-93. PubMed ID: 23729031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis.
    Sardar P; Kundu A; Chatterjee S; Feldman DN; Owan T; Kakouros N; Nairooz R; Pape LA; Feldman T; Dawn Abbott J; Elmariah S
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):504-515. PubMed ID: 28398671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.
    Conte JV; Hermiller J; Resar JR; Deeb GM; Gleason TG; Adams DH; Popma JJ; Yakubov SJ; Watson D; Guo J; Zorn GL; Reardon MJ
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):321-330. PubMed ID: 29195573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The aortic valve calcium nodule score (AVCNS) independently predicts paravalvular regurgitation after transcatheter aortic valve replacement (TAVR).
    Azzalini L; Ghoshhajra BB; Elmariah S; Passeri JJ; Inglessis I; Palacios IF; Abbara S
    J Cardiovasc Comput Tomogr; 2014; 8(2):131-40. PubMed ID: 24661826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.
    Shah AM; Ogbara J; Herrmann HC; Fox Z; Kadakia M; Anwaruddin S; Bavaria JE; Desai ND; Jagasia D; Szeto WY; Li RH; Vallabhajosyula P; Giri J
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):888-94. PubMed ID: 25963625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.
    Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Zeus T; Pilgrim T; Schofer J; Zweiker D; Testa L; Taramasso M; Hildick-Smith D; Abizaid A; Wolf A; Van Mieghem NM; Sedaghat A; Wöhrle J; Khogali S; Van der Heyden JAS; Webb JG; Estévez-Loureiro R; Mylotte D; MacCarthy P; Brugaletta S; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Veulemans V; Asami M; Windecker S; Eitan A; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Alsanjari O; Siqueira D; Jensen CJ; Naber CK; Ziviello F; Sinning JM; Seeger J; Rottbauer W; Brouwer J; Alenezi A; Wood DA; Tzalamouras V; Regueiro A; Colombo A; Latib A
    JACC Cardiovasc Interv; 2019 Mar; 12(5):433-443. PubMed ID: 30846081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct Comparison of Feasibility and Safety of Transfemoral Versus Transaortic Versus Transapical Transcatheter Aortic Valve Replacement.
    Arai T; Romano M; Lefèvre T; Hovasse T; Farge A; Le Houerou D; Hayashida K; Watanabe Y; Garot P; Benamer H; Unterseeh T; Bouvier E; Morice MC; Chevalier B
    JACC Cardiovasc Interv; 2016 Nov; 9(22):2320-2325. PubMed ID: 27884356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement.
    Lardizabal JA; Macon CJ; O'Neill BP; Desai H; Singh V; Martinez CA; Alfonso CE; Cohen MG; Heldman AW; O'Neill WW; Williams DB
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1226-30. PubMed ID: 25511236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transaortic approach for transcatheter aortic valve implantation: a valid alternative to the transapical access in patients with no peripheral vascular option. A single center experience.
    Hayashida K; Romano M; Lefèvre T; Chevalier B; Farge A; Hovasse T; Le Houerou D; Morice MC
    Eur J Cardiothorac Surg; 2013 Oct; 44(4):692-700. PubMed ID: 23439694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes Following Subclavian and Axillary Artery Access for Transcatheter Aortic Valve Replacement: Society of the Thoracic Surgeons/American College of Cardiology TVT Registry Report.
    Dahle TG; Kaneko T; McCabe JM
    JACC Cardiovasc Interv; 2019 Apr; 12(7):662-669. PubMed ID: 30947940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
    Kolte D; Khera S; Vemulapalli S; Dai D; Heo S; Goldsweig AM; Aronow HD; Elmariah S; Inglessis I; Palacios IF; Thourani VH; Sharaf BL; Gordon PC; Abbott JD
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1175-1185. PubMed ID: 29929641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
    Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
    JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes following transcatheter aortic valve replacement in the United States.
    Mack MJ; Brennan JM; Brindis R; Carroll J; Edwards F; Grover F; Shahian D; Tuzcu EM; Peterson ED; Rumsfeld JS; Hewitt K; Shewan C; Michaels J; Christensen B; Christian A; O'Brien S; Holmes D;
    JAMA; 2013 Nov; 310(19):2069-77. PubMed ID: 24240934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prosthetic Mitral Surgical Valve in Transcatheter Aortic Valve Replacement Recipients: A Multicenter Analysis.
    Amat-Santos IJ; Cortés C; Nombela Franco L; Muñoz-García AJ; Suárez De Lezo J; Gutiérrez-Ibañes E; Serra V; Larman M; Moreno R; De La Torre Hernandez JM; Puri R; Jimenez-Quevedo P; Hernández García JM; Alonso-Briales JH; García B; Lee DH; Rojas P; Sevilla T; Goncalves R; Vera S; Gómez I; Rodés-Cabau J; San Román JA
    JACC Cardiovasc Interv; 2017 Oct; 10(19):1973-1981. PubMed ID: 28982562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.